Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?

Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, Joseph Ciccolini, Laurent Greillier, Nicolas Andre, Fabrice Barlesi, Celine Mascaux

Source: Eur Respir Rev, 27 (147) 170098; 10.1183/16000617.0098-2017
Journal Issue: March
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, Joseph Ciccolini, Laurent Greillier, Nicolas Andre, Fabrice Barlesi, Celine Mascaux. Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?. Eur Respir Rev, 27 (147) 170098; 10.1183/16000617.0098-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016


Malignant pleural mesothelioma: new treatments, new hopes?
Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017
Year: 2017


Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014



Pleurodesis for malignant pleural effusion: which compound?
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Pleurodesis for malignant pleural effusion: which compound?
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012

Management of malignant pleural mesothelioma in 2017
Source: ERS Skills course - Medical thoracoscopy
Year: 2017

Volatile organic compounds increase the likelihood of detecting malignant pleural mesothelioma
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015


Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012

Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015

Exhaled breath to screen for malignant pleural mesothelioma: a validation study
Source: Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017
Year: 2017



Non-malignant pleural disease from asbestos and malignant pleural mesothelioma
Source: Eur Respir Monogr 2020; 89: 141-149
Year: 2020